Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure
Aim. To assess carvedilol and bisoprolol effects on clinical symptoms, hemodynamics and morpho-functional heart characteristics in patients with myocardial infarction (MI) and chronic heart failure (CHF).Material and methods. The study included 40 patients with CHF and MI, randomized into two groups...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2008-06-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1529 |
id |
doaj-963f7cc912354924b594307761324d71 |
---|---|
record_format |
Article |
spelling |
doaj-963f7cc912354924b594307761324d712021-07-28T13:50:46Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252008-06-017368731247Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failureA. I. Chesnikova0E. A. Lavrik1I. V. Bedareva2I. N. Koshenskaya3Rostov State Medical University. Rostov-na-DonuRostov State Medical University. Rostov-na-DonuRostov State Medical University. Rostov-na-DonuRostov State Medical University. Rostov-na-DonuAim. To assess carvedilol and bisoprolol effects on clinical symptoms, hemodynamics and morpho-functional heart characteristics in patients with myocardial infarction (MI) and chronic heart failure (CHF).Material and methods. The study included 40 patients with CHF and MI, randomized into two groups: Group I (n=20) received standard therapy and carvedilol, Group II (n=20) - standard therapy and bisoprolol.Results. In both groups, the therapy was associated with substantial clinical improvement and decrease in most parameters of circadian blood pressure (BP) profile. Carvedilol therapy was linked to greater reduction in daytime and nighttime systolic and diastolic BP variability. Significant reduction in left ventricular (LV) wall thickness and LV myocardial mass was observed in both groups.Conclusion. Additional therapy with carvedilol and bisoprolol improved clinical status of patients with MI and CHF. Carvedilol therapy had greater and more stable antihypertensive effect. After 12 weeks of carvedilol or bisoprolol treatment, similar LV hypertrophy (LVH) regression was observed. Carvedilol therapy was associated not only with LVH regression, but also with substantially increased LV contractility, improved LV diastolic function, and normalized diastole structure.https://cardiovascular.elpub.ru/jour/article/view/1529chronic heart failuremyocardial infarctionbeta-adrenoblockers |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
A. I. Chesnikova E. A. Lavrik I. V. Bedareva I. N. Koshenskaya |
spellingShingle |
A. I. Chesnikova E. A. Lavrik I. V. Bedareva I. N. Koshenskaya Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure Кардиоваскулярная терапия и профилактика chronic heart failure myocardial infarction beta-adrenoblockers |
author_facet |
A. I. Chesnikova E. A. Lavrik I. V. Bedareva I. N. Koshenskaya |
author_sort |
A. I. Chesnikova |
title |
Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure |
title_short |
Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure |
title_full |
Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure |
title_fullStr |
Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure |
title_full_unstemmed |
Carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure |
title_sort |
carvedilol and bisoprolol effectiveness in patients with myocardial infarction and heart failure |
publisher |
«SILICEA-POLIGRAF» LLC |
series |
Кардиоваскулярная терапия и профилактика |
issn |
1728-8800 2619-0125 |
publishDate |
2008-06-01 |
description |
Aim. To assess carvedilol and bisoprolol effects on clinical symptoms, hemodynamics and morpho-functional heart characteristics in patients with myocardial infarction (MI) and chronic heart failure (CHF).Material and methods. The study included 40 patients with CHF and MI, randomized into two groups: Group I (n=20) received standard therapy and carvedilol, Group II (n=20) - standard therapy and bisoprolol.Results. In both groups, the therapy was associated with substantial clinical improvement and decrease in most parameters of circadian blood pressure (BP) profile. Carvedilol therapy was linked to greater reduction in daytime and nighttime systolic and diastolic BP variability. Significant reduction in left ventricular (LV) wall thickness and LV myocardial mass was observed in both groups.Conclusion. Additional therapy with carvedilol and bisoprolol improved clinical status of patients with MI and CHF. Carvedilol therapy had greater and more stable antihypertensive effect. After 12 weeks of carvedilol or bisoprolol treatment, similar LV hypertrophy (LVH) regression was observed. Carvedilol therapy was associated not only with LVH regression, but also with substantially increased LV contractility, improved LV diastolic function, and normalized diastole structure. |
topic |
chronic heart failure myocardial infarction beta-adrenoblockers |
url |
https://cardiovascular.elpub.ru/jour/article/view/1529 |
work_keys_str_mv |
AT aichesnikova carvedilolandbisoprololeffectivenessinpatientswithmyocardialinfarctionandheartfailure AT ealavrik carvedilolandbisoprololeffectivenessinpatientswithmyocardialinfarctionandheartfailure AT ivbedareva carvedilolandbisoprololeffectivenessinpatientswithmyocardialinfarctionandheartfailure AT inkoshenskaya carvedilolandbisoprololeffectivenessinpatientswithmyocardialinfarctionandheartfailure |
_version_ |
1721271366069518336 |